OptiNose Cash from Financing (Quarterly) Analysis

OptiNose Inc (OPTN)

0.88 -0.03 (-3.12%) USD | NASDAQ | May 02, 16:00

0.88 0.00 (0.00%) After-Hours: 16:46

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	0.004M
September 30, 2023	0.135M
June 30, 2023	-0.001M
March 31, 2023	0.162M
December 31, 2022	50.79M
September 30, 2022	0.373M
June 30, 2022	0.027M
March 31, 2022	0.249M
December 31, 2021	43.01M
September 30, 2021	0.035M
June 30, 2021	0.347M
March 31, 2021	-0.071M
December 31, 2020	20.31M
September 30, 2020	33.55M

Date	Value
June 30, 2020	0.572M
March 31, 2020	29.38M
December 31, 2019	39.83M
September 30, 2019	-3.283M
June 30, 2019	0.793M
March 31, 2019	0.188M
December 31, 2018	-0.083M
September 30, 2018	1.185M
June 30, 2018	60.17M
March 31, 2018	-1.693M
December 31, 2017	200.41M
September 30, 2017	-0.721M
June 30, 2017	1.619M
March 31, 2017	34.82M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-3.283M

Minimum

Sep 2019

50.79M

Maximum

Dec 2022

11.38M

Average

0.347M

Median

Jun 2021

Cash from Financing (Quarterly) Benchmarks

Madrigal Pharmaceuticals Inc	479.92M
Viking Therapeutics Inc	606.04M
Zevra Therapeutics Inc	5.004M
Spero Therapeutics Inc	0.001M
Karuna Therapeutics Inc (DELISTED)	19.87M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	6.909M
Cash from Investing (Quarterly)	-0.073M
Free Cash Flow	-20.86M
Free Cash Flow Per Share (Quarterly)	0.0609
Free Cash Flow to Equity (Quarterly)	6.422M
Free Cash Flow Yield	-21.15%